The Royal College of Obstetricians and Gynaecologists (RCOG) understands that the Joint Committee on Vaccination and Immunisation’s decision to choose the bivalent vaccine in 2008 was based on the brief to inoculate against cervical cancer caused by the strains of HPV 16 and 18.
